Literature DB >> 10926556

Quantitative trait locus mapping of genes regulating pulmonary PKC activity and PKC-alpha content.

L D Dwyer-Nield1, B Paigen, S E Porter, A M Malkinson.   

Abstract

Strain A/J mice, which are predisposed to experimentally induced asthma and adenocarcinoma, have the lowest pulmonary protein kinase (PK) C activity and content among 22 inbred mouse strains. PKC in neonatal A/J mice is similar to that in other strains, so this difference reflects strain-dependent postnatal regulation. PKC activity is 60% higher in C57BL/6J (B6) than in A/J lungs, and the protein and mRNA concentrations of PKC-alpha, the major pulmonary PKC isozyme, are two- to threefold higher in B6 mice. These differences result from more than a single gene as assessed in F(1), F(2), and backcross progeny of B6 and A/J parents. Quantitative trait locus (QTL) analysis of 23 AxB and BxA recombinant inbred strains derived from B6 and A/J progenitors indicates a major locus regulating lung PKC-alpha content that maps near the Pkcalpha structural gene on chromosome 11 (D11MIT333; likelihood ratio statistic = 12.5) and a major locus controlling PKC activity that maps on chromosome 3 (D3MIT19; likelihood ratio statistic = 15.4). The chromosome 11 QTL responsible for low PKC-alpha content falls within QTLs for susceptibilities to lung tumorigenesis and ozone-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926556     DOI: 10.1152/ajplung.2000.279.2.L326

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  2 in total

1.  Parental genetic contributions in the AXB and BXA recombinant inbred mouse strains.

Authors:  Daniel R Prows; Michelle L Horner
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

2.  Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking.

Authors:  Ralf-Harto Hübner; Jamie D Schwartz; P De Bishnu; Barbara Ferris; Larsson Omberg; Jason G Mezey; Neil R Hackett; Ronald G Crystal
Journal:  Mol Med       Date:  2009-03-20       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.